# AD bulk meta-analysis (multi-cohort) (P21)

**Theme:** T3 Neurodegeneration | **Year:** 2025

## RQ
What robust DE signatures track AD pathology?

## Hypothesis
Glial activation and synaptic loss signatures reproduce across cohorts.

## Methods
limma-voom; random-effects; GSVA

## Datasets
recount3/GEO (ROSMAP/MSBB/Mayo)
